Skip to main content
SpringerLink
Log in

CTV for Lymphatics in Prostate Adenocarcinoma: an Anatomical Description and Clinical Discussion

  • Chapter
Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 278 Accesses

Abstract

The prognosis for patients diagnosed as having prostate cancer is influenced by several factors: the grade of differentiation (Gleason grade), the tumour size and its extension into the periprostatic tissue, any extension in the proximal lymphatics, and the possible presence of metastases (usually in the bones, but sometimes in the extra-pelvic lymph nodes).

The presentation of a definite outlook is of more value than the discussion of different principles and practices. It does not mean to imply that it is the only way, or the best, or the most correct method but may leave the reader with something concrete

R. Paterson (1948)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alagiri M, Colton MD, Seidmon EJ et al (1997) The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer. Br J Urol 80: 243–246

    Article  CAS  PubMed  Google Scholar 

  • Asbell SO, Krall JM, Pilepich ME et al (1988) Elective pelvic irradiation in stage A-2, B carcinoma of the prostate: analysis of RTOG 77–06. IJROBP 15: 1306–1316

    Google Scholar 

  • Bagshaw MA (1984) Radiotherapeutic treatment of prostatic carcinoma with pelvic node involvement. Urol Clin North Am 11: 297–304

    CAS  PubMed  Google Scholar 

  • Bagshaw MA, Pistenma DA, Ray GR et al (1977) Evaluation of extended-field radiotherapy for prostatic neoplasms: 1976 progress report. Cancer Treat Rep 61: 297–306

    CAS  PubMed  Google Scholar 

  • Bagshaw MA, Kaplan ID, Cox RC (1993) Prostate cancer. Radiation therapy for localized disease. Cancer 71: 939–952

    Google Scholar 

  • Beard CJ, Propert KJ, Rieker PP et al (1997) Complications after treatment with external-beam irradiation in early stage prostate cancer patients: a prospective multiinstitutional outcomes study. JCO 15: 223–229

    CAS  Google Scholar 

  • Bishoff JT, Reyes A, Thompson IM et al (1995) Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45: 270–274

    Article  CAS  PubMed  Google Scholar 

  • Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE (1994) Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151: 1315–1320

    CAS  PubMed  Google Scholar 

  • Bolla M, Gonzalez D, Warde P et al (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. NEJM 337: 295–300

    Article  CAS  PubMed  Google Scholar 

  • Bostwick DG, Wheeler TM, Blute M et al (1996) Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 48: 47–57

    Article  CAS  PubMed  Google Scholar 

  • Buskirk SJ, Pisansky TM, Atkinson EJ et al (2001) Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy. Mayo Clin Proc 76: 702–706

    Article  CAS  PubMed  Google Scholar 

  • Campbell SC, Klein EA, Levin HS, Piedmonte MR (1995) Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology 46: 352–355

    Article  CAS  PubMed  Google Scholar 

  • Catalona WJ, Smith DS, Ratliff TL et al (1993) Detection of organ confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948–954

    Article  CAS  PubMed  Google Scholar 

  • Clements R, Griffiths GJ, Peeling WB (1992) Staging prostatic cancer. Clin Radiol 46: 225–231

    Article  CAS  PubMed  Google Scholar 

  • D’Amico AV, Whittington R, Malkowicz SB et al (1996) Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients. Cancer J Sci Am 2: 343

    PubMed  Google Scholar 

  • Danella JF, deKernion JB, Smith RB, Steckel J (1993) The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 149: 1488–1491

    CAS  PubMed  Google Scholar 

  • Dinges S, Deger S, Koswig S et al (1998) High-dose rate interstitial with external beam irradiation for localised prostate cancer: results of a prospective trial. Radiother Oncol 48: 197–202

    Article  CAS  PubMed  Google Scholar 

  • Dugan JA, Bostwick DG, Myers RP et al (1996) The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 275: 288–294

    Article  CAS  PubMed  Google Scholar 

  • Eastham JA, May R, Robertson JL et al (1999) Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. Urology 54: 709–713

    Article  CAS  PubMed  Google Scholar 

  • Engeler CE, Wasserman NF, Zhang G (1992) Preoperative assessment of prostatic carcinoma by computerised tomography. Weaknesses and new perspectives. Urology 40: 346–350

    Google Scholar 

  • Flanigan RC, McKay TC, Olson M et al (1996) Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 48: 428–432

    Article  CAS  PubMed  Google Scholar 

  • Fletcher GH (1973) Textbook of radiotherapy. Lea and Febiger, Philadelphia

    Google Scholar 

  • Forman JD, Lee Y, Roberson P et al (1993) Advantages of CT and Beam eye’s view display to confirm the accuracy of pelvic lymph node irradiation in carcinoma of the prostate. Radiology 186: 889–892

    Article  CAS  PubMed  Google Scholar 

  • Gerber GS, Bales GT, Gornik HL et al (1996) Treatment of prostate cancer using external beam radiotherapy afterr laparoscopic pelvic node dissection. Br J Urol 77: 870–875

    Article  CAS  PubMed  Google Scholar 

  • Glajchen N, Shapiro RD Stock RG et al (1996) CT findings after laparoscopic pelvic lymph node dissection and transperineal radioactive seed implantation for prostatic carcinoma. Am J Roentgenol 166: 1165–1168

    Article  CAS  Google Scholar 

  • Granfors T, Modig H, Damber JE, Tomic R (1998) Combined orchiectomy and external radiotherapy versus radiotherapy alone for non metastatic prostate cancer with or without pelvic node involvement: a prospective randomised study. J Urol 159: 2030–2034

    Article  CAS  PubMed  Google Scholar 

  • Greskovich FJ, Zagars GK, Sherman NE and Johnson DE (1991) Complications following external beam radiation therapy for prostate cancer: an analysis of patients treated with and without staging pelvic lymphadenectomy. J Urol 146: 798–802

    CAS  PubMed  Google Scholar 

  • Hankey BF, Feuer EJ, Clegg LX et al (1999) Cancer surveillance series: interpreting trends in prostate cancer, part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates. JNCI 91: 1017–1024

    Google Scholar 

  • Hanks GE, Krall JM, Pilepich MV et al (1992) Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: implications of RTOG data for patient management and trial design and stratification. IJROBP 23: 293–298

    CAS  Google Scholar 

  • Harisinghani MG, Saini S, Slater GJ, Schnall MD, Rifkin MD (1997) MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations. J Magn Reson Imaging 7: 161–163

    Article  CAS  PubMed  Google Scholar 

  • Horwitz EM, Hanlon AL, Pinover W, Hanks GE (1998) The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy. IJROBP 41: 519–523

    CAS  Google Scholar 

  • Huncharek M, Muscat J (1995) Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. Cancer Invest 13: 31–35

    Article  CAS  PubMed  Google Scholar 

  • Huncharek M, Muscat J (1996) Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer. Abdominal Imaging 21: 364–367

    Article  CAS  PubMed  Google Scholar 

  • Kattan MW, Cowen ME, Miles BJ (1997) A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med 12: 299–305

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kleer E, Larson-Keller JJ, Zincke H, Oesterling JE (1993) Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade. Urology 41: 207–216

    Google Scholar 

  • Kurup P, Kramer TS, Lee MS et al (1984) External beam irradiation of prostate cancer: experience in 163 patients. Cancer 53: 37–43

    Article  CAS  PubMed  Google Scholar 

  • Lamb HM, Faulds D (1998) Capromab pendetide. A review of its use as an imaging agent in prostate cancer. Drugs 12: 293–304

    Google Scholar 

  • Laverdière J, Gomez JL, Cusan L et al (1997) Beneficial effect of combination hormonal therapy administered prior and following external beam radiation, therapy in localised prostate cancer. IJROBP 37: 247–252

    Google Scholar 

  • Leibel SA, Fuks Z, Zelefsky MF, Whitmore WF Jr (1994) The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. IJROBP 28: 7–16

    CAS  Google Scholar 

  • Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H (1996) Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 156: 137–143

    Article  CAS  PubMed  Google Scholar 

  • Levran Z, Gonzalez JA, Diokno AC et al (1995) Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? Br J Urol 75: 778–781

    Article  CAS  PubMed  Google Scholar 

  • Mameghan H, Fisher R, Mameghan J et al (1990) Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect. Int J Radiat Oncol Biol Phys 18: 315–320

    Article  CAS  PubMed  Google Scholar 

  • Mc Neal JE (1968) Regional morphology and pathology of the prostate. Am J Surg Pathol 49: 347–357

    Google Scholar 

  • Mc Neal JE, Redwine EA, Freiha FS et al (1988) Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol 12: 898–906

    Google Scholar 

  • Narayan P, Gajendran V, Taylor SP, Tewari A, Presti JC Jr, Lei-dich R, Lo R, Palmer K, Shinohara K, Spaulding JT (1995) The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology 46: 205–212

    Article  CAS  PubMed  Google Scholar 

  • Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC (1993) The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269: 57–60

    Article  CAS  PubMed  Google Scholar 

  • Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337: 949–955

    Article  CAS  PubMed  Google Scholar 

  • Parra RO, Andrus CH, Boullier JA (1992) Staging laparoscopic pelvic lymph node dissection. Experience and indications. Arch Surg 127: 1294–1297

    Google Scholar 

  • Partin AW, Walsh PC (1994) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 152: 172–173

    CAS  PubMed  Google Scholar 

  • Partin AW, Kattan MW, Subong EN et al (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277: 1445–1451

    Google Scholar 

  • Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD (2001) Contemporary update of prostate cancer staging nomograms ( Partin Tables) for the new millennium. Urology 58: 843–848

    Google Scholar 

  • Paterson R (1948) Treatment of malignant disease by radium and X-rays; a practice of radiotherapy. Williams and Wilkins, Baltimore

    Google Scholar 

  • Paulson DF, Cline WA Jr, Koefoot RB et al (1982) Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma. J Urol 127: 935–937

    CAS  PubMed  Google Scholar 

  • Perez CA, Lee HK, Georgiou A, Lockett MA (1994) Technical factors affecting morbidity in definitive irradiation for localised carcinoma of the prostate. IJROBP 28: 811–819

    CAS  Google Scholar 

  • Perrotti M, Gentle DL, Barada_JH et al (1996) Mini-laparotomy pelvic lymph node dissection minimizes morbidity, hospitalization and cost of pelvic lymph node dissection. J Urol 155: 986–988

    Article  CAS  PubMed  Google Scholar 

  • Pilepich MV, Krall JM, Johnson RJ et al (1986) Extended field (periaortic) irradiation in carcinoma of the prostate-analysis of RTOG 75–06. IJROBP 12: 345–351

    CAS  Google Scholar 

  • Pilepich MV, Krall JM, Sause WT et al (1987) Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate: Analysis of RTOG study 75–06.IJROBP 13: 351–357

    Google Scholar 

  • Pilepich MV, Caplan R, Byhardt RW et al (1997) Phase III trial of androgen suppression using Goserelin in unfavourable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of RTOG 85–31. JCO 15: 1013–1021

    CAS  Google Scholar 

  • Pisansky TM, Kahn MJ, Rasp GM, Cha SS, Haddock MG, Bostwick DG (1997) A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma. Cancer 79: 337–344

    Article  CAS  PubMed  Google Scholar 

  • Poirier P, Cuneo B, Delamere G (1903) The lymphatics. Archibald Constable, Westminster, pp 175–182

    Google Scholar 

  • Polascik TJ, Oesterling JE, Partin AW (1999) Prostate specific antigen: a decade of discovery–what we have learned and where we are going. J Urol 162: 293–306

    Article  CAS  PubMed  Google Scholar 

  • Powell IJ, Heilbrun LK, Sakr W et al (1997) The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins. Urology 49: 726–731

    Article  CAS  PubMed  Google Scholar 

  • Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal

    Google Scholar 

  • women with breast cancer. N Engl J Med 337:956–962

    Google Scholar 

  • Rees MA, Resnick MI, Oesterling JE (1997) Use of prostate-specific antigen, Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer. Urol Clin North Am 24: 379–388

    Google Scholar 

  • Remouchamps V, Richard F, Lhoas F et al (1998) Mixed photon-neutron radiotherapy in prostate cancer: a retrospective quality of life study. Radiother Oncol 48: S67

    Google Scholar 

  • Rietbergen JB, Hoedemaeker RF, Kruger_AE et al (1999) The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study. J Urol 161: 1192–1198

    Article  CAS  PubMed  Google Scholar 

  • Rosen E, Cassady R, Connolly JR et al (1985) Radiotherapy for prostate carcinoma: the JCRT experience (1968–1978). II. Factors related to tumour control and complications. IJROBP 11: 725–730

    Google Scholar 

  • Rukstalis DB, Gerber GS, Vogelzang NJ et al (1994) Laparoscopic pelvic lymph node dissection: a review of 103 consecutive cases. J Urol 151: 670–674

    CAS  PubMed  Google Scholar 

  • Schmid HP, Mihatsch MJ, Hering F, RutishauserG (1997) Impact of minimal lymph node metastasis on long-term prognosis after radical prostatectomy. Eur Urol 31: 11–16

    CAS  Google Scholar 

  • Schröder FH, Kranse R, Rietbergen JB et al (1999) The European Randomized Study of Screening for Prostate Cancer (ERSPC): an update. Members of the ERSPC, Section Rotterdam. Eur Urol 35: 539–543

    Google Scholar 

  • Smith JA Jr, Middleton RG (1985) Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate. J Urol 133: 617–619

    PubMed  Google Scholar 

  • Spevack L, Killion LT, West JC et al (1996) Predicting the patient at low risk for lymph node metastasis with localized prostate cancer: an analysis of four statistical models. Int J Radiat Oncol Biol Phys 34: 543–547

    Article  CAS  PubMed  Google Scholar 

  • Testut L, Latarjet A (1931) Traité d’anatomie humaine. Tome cinquième: appareil urogénital-péritoine. Gaston Doin, Paris, pp 264–268

    Google Scholar 

  • Walsh PC, Mostwin JL (1984) Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol 56: 694–697

    Google Scholar 

  • Zagars GK, Pollack A, von Eschenbach AC (2001) Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. Urology 58: 233–239

    Article  CAS  PubMed  Google Scholar 

  • Zelefsky MJ, Leibel SA, Gaudin PB et al (1998) Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. IJROBP 41: 491–500

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University Hospital Saint Luc, Université Catholique de Louvain, 10 Avenue Hippocrate, 1200, Brussels, Belgium

    P. Scalliet MD, PhD & L. Renard MD

  2. Department of Anatomy, University Hospital Saint Luc, Université Catholique de Louvain, 10 Avenue Hippocrate, 1200, Brussels, Belgium

    B. Lengelé MD, PhD

  3. Department of Urology, University Hospital Saint Luc, Université Catholique de Louvain, 10 Avenue Hippocrate, 1200, Brussels, Belgium

    B. Tombal MD, PhD

Authors
  1. P. Scalliet MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Renard MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Lengelé MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Tombal MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Université Catholique de Louvain Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, UCL 10/4752, 1200, Bruxelles, Belgium

    Vincent Grégoire MD, PhD  & Pierre Scalliet MD, PhD  & 

  2. Department of Radiation Oncology, UT MD Anderson Cancer Center, 77030, Houston, TX, USA

    K. Kian Ang MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Scalliet, P., Renard, L., Lengelé, B., Tombal, B. (2004). CTV for Lymphatics in Prostate Adenocarcinoma: an Anatomical Description and Clinical Discussion. In: Grégoire, V., Scalliet, P., Ang, K.K. (eds) Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06270-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06270-8_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-07463-9

  • Online ISBN: 978-3-662-06270-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation